News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
624,874 Results
Type
Article (36971)
Company Profile (115)
Press Release (587788)
Multimedia
Podcasts (45)
Webinars (9)
Section
Business (172363)
Career Advice (2753)
Deals (32323)
Drug Delivery (87)
Drug Development (72468)
Employer Resources (158)
FDA (15589)
Job Trends (14538)
News (299678)
Policy (28897)
Tag
Academia (2666)
Academic (1)
Accelerated approval (5)
Adcomms (24)
Allergies (98)
Alliances (43270)
ALS (106)
Alzheimer's disease (1448)
Antibody-drug conjugate (ADC) (136)
Approvals (15601)
Artificial intelligence (289)
Autoimmune disease (31)
Automation (17)
Bankruptcy (289)
Best Places to Work (12092)
BIOSECURE Act (17)
Biosimilars (102)
Biotechnology (82)
Bladder cancer (89)
Brain cancer (30)
Breast cancer (348)
Cancer (2668)
Cardiovascular disease (194)
Career advice (2284)
Career pathing (31)
CAR-T (179)
CDC (22)
Cell therapy (491)
Cervical cancer (20)
Clinical research (59789)
Collaboration (953)
Company closure (2)
Compensation (632)
Complete response letters (19)
COVID-19 (2488)
CRISPR (58)
C-suite (302)
Cystic fibrosis (113)
Data (2820)
Decentralized trials (1)
Denatured (8)
Depression (50)
Diabetes (290)
Diagnostics (6643)
Digital health (20)
Diversity (3)
Diversity, equity & inclusion (39)
Drug discovery (124)
Drug pricing (101)
Drug shortages (20)
Duchenne muscular dystrophy (111)
Earnings (69005)
Editorial (42)
Employer branding (21)
Employer resources (139)
Events (103613)
Executive appointments (861)
FDA (17123)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (863)
Gene editing (128)
Generative AI (20)
Gene therapy (363)
GLP-1 (641)
Government (4080)
Grass and pollen (5)
Guidances (174)
Healthcare (19852)
Huntington's disease (26)
IgA nephropathy (33)
Immunology and inflammation (127)
Immuno-oncology (5)
Indications (36)
Infectious disease (2641)
Inflammatory bowel disease (151)
Inflation Reduction Act (9)
Influenza (57)
Intellectual property (114)
Interviews (543)
IPO (16229)
IRA (34)
Job creations (2867)
Job search strategy (1891)
Kidney cancer (15)
Labor market (36)
Layoffs (444)
Leadership (24)
Legal (6372)
Liver cancer (68)
Lung cancer (364)
Lymphoma (185)
Machine learning (9)
Management (59)
Manufacturing (344)
MASH (85)
Medical device (14051)
Medtech (14056)
Mergers & acquisitions (16854)
Metabolic disorders (691)
Multiple sclerosis (91)
NASH (13)
Neurodegenerative disease (115)
Neuropsychiatric disorders (27)
Neuroscience (2085)
NextGen: Class of 2025 (6713)
Non-profit (4831)
Now hiring (34)
Obesity (331)
Opinion (236)
Ovarian cancer (94)
Pain (110)
Pancreatic cancer (105)
Parkinson's disease (185)
Partnered (20)
Patents (274)
Patient recruitment (139)
Peanut (51)
People (51896)
Pharmaceutical (33)
Pharmacy benefit managers (19)
Phase I (18655)
Phase II (26543)
Phase III (19772)
Pipeline (1534)
Policy (155)
Postmarket research (2017)
Preclinical (7663)
Press Release (62)
Prostate cancer (126)
Psychedelics (30)
Radiopharmaceuticals (263)
Rare diseases (444)
Real estate (4894)
Recruiting (63)
Regulatory (20674)
Reports (30)
Research institute (2442)
Resumes & cover letters (450)
Rett syndrome (9)
RNA editing (6)
RSV (46)
Schizophrenia (81)
Series A (139)
Series B (99)
Service/supplier (6)
Sickle cell disease (63)
Special edition (14)
Spinal muscular atrophy (146)
Sponsored (25)
Startups (3036)
State (2)
Stomach cancer (7)
Supply chain (69)
Tariffs (49)
The Weekly (36)
Vaccines (685)
Venture capitalists (39)
Weight loss (180)
Women's health (31)
Worklife (18)
Date
Today (150)
Last 7 days (523)
Last 30 days (2518)
Last 365 days (32447)
2025 (15510)
2024 (35954)
2023 (41286)
2022 (52115)
2021 (57039)
2020 (55564)
2019 (48731)
2018 (36629)
2017 (32101)
2016 (30368)
2015 (35472)
2014 (24629)
2013 (19205)
2012 (20726)
2011 (21532)
2010 (18623)
Location
Africa (759)
Alabama (63)
Alaska (7)
Arizona (166)
Arkansas (12)
Asia (36426)
Australia (6477)
California (7198)
Canada (2267)
China (630)
Colorado (308)
Connecticut (321)
Delaware (183)
Europe (84402)
Florida (1085)
Georgia (250)
Idaho (59)
Illinois (624)
India (24)
Indiana (352)
Iowa (16)
Japan (208)
Kansas (106)
Kentucky (29)
Louisiana (13)
Maine (73)
Maryland (990)
Massachusetts (5479)
Michigan (260)
Minnesota (438)
Mississippi (2)
Missouri (93)
Montana (31)
Nebraska (25)
Nevada (78)
New Hampshire (70)
New Jersey (2015)
New Mexico (30)
New York (2028)
North Carolina (1108)
North Dakota (10)
Northern California (3188)
Ohio (235)
Oklahoma (15)
Oregon (35)
Pennsylvania (1562)
Puerto Rico (16)
Rhode Island (37)
South America (1082)
South Carolina (33)
South Dakota (1)
Southern California (2714)
Tennessee (119)
Texas (1065)
United States (26953)
Utah (221)
Virginia (178)
Washington D.C. (69)
Washington State (621)
West Virginia (3)
Wisconsin (72)
624,874 Results for "recipharm ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Recipharm and PLG announce strategic partnership to accelerate development projects
May 13, 2025
·
4 min read
Press Releases
Notice To Extraordinary General Meeting In Alzecure Pharma AB
June 16, 2025
·
7 min read
Press Releases
Notice of Extra General Meeting in Biovica International AB
June 11, 2025
·
16 min read
Press Releases
AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036
June 12, 2025
·
4 min read
Press Releases
Report from the Annual General Meeting 2025 of IRLAB Therapeutics AB
June 12, 2025
·
7 min read
Press Releases
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
April 23, 2025
·
7 min read
Press Releases
AB Science announces EMA approval of Masivet shelf-life extension to 4 years
June 9, 2025
·
3 min read
Press Releases
Notice to the Annual General Meeting in IRLAB Therapeutics AB
May 12, 2025
·
1 min read
Bio NC
Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs
Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Group to form a new standalone company.
April 2, 2024
·
4 min read
Press Releases
Bulletin from the 2025 Annual General Meeting of Spago Nanomedical AB
May 15, 2025
·
2 min read
1 of 62,488
Next
